Saturday, July 24, 2021

Latest Posts

Actinogen Medical: Files new patent applications

  • Actinogen Medical (ACW) is set to expand its intellectual property portfolio with two new patents
  • The healthcare stock filed the applications for its lead drug candidate, an Alzheimer’s treatment known as Xanamen
  • Positively, the new submissions could extend the drug’s patent life protection up to 2040
  • ACW’s first patent covers a process which seeks to improve cognitive function or treat cognitive decline in healthy adults
  • Meanwhile, the second patent will protect Actinogen’s scale-up manufacturing process
  • Actinogen closed steady following today’s news, with shares worth 2.2 cents each

Latest Posts

Don't Miss